AIOM
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
AIOM
Jun 22, 2024, 04:17 |
Insight
Massimo Di Maio: Bone health and body composition in prostate cancer
Massimo Di Maio, Medical Oncologist at Molinette Hospital, Turin, shared on X: “Italian collaboration on…
Jun 10, 2024, 10:01 |
Blog
Alessandra Curioni Fontecedro: Giuseppe Curigliano represents ESMO for me
Alessandra Curioni Fontecedro, Head of Medical Oncology at HFR Fribourg – Cantonal Hospital, shared Antonio…
Jun 6, 2024, 11:44 |
Blog
Angelo Dipasquale: Prognostic signature of patients with astrocytoma IDHm G4
Angelo Dipasquale, Medical Oncologist at Humanitas Research Hospital, shared a post on LinkedIn: "Just out…
Apr 15, 2024, 13:12 |
Blog
Lynn Schuchter: My pleasure to deliver welcome remarks to the ASCO - Italian Association of Medical Oncology Clinical Research Course
Lynn Schuchter shared a post on X: "It was my pleasure to deliver welcome remarks…
Mar 6, 2024, 11:40 |
Blog
Roberto Iacovelli: Great discussions on GU news in Rome
Roberto Iacovelli, Associate Professor of Medical Oncology at Catholic University, Comprehensive Cancer Center of Rome…
All:
5
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube